Literature DB >> 28104743

Active Brown Fat During 18F-FDG PET/CT Imaging Defines a Patient Group with Characteristic Traits and an Increased Probability of Brown Fat Redetection.

Carlos Gerngroß1, Johanna Schretter2, Martin Klingenspor3,4, Markus Schwaiger2, Tobias Fromme3,4.   

Abstract

Brown adipose tissue (BAT) provides a means of nonshivering thermogenesis. In humans, active BAT can be visualized by 18F-FDG uptake as detected by PET combined with CT. The retrospective analysis of clinical scans is a valuable source to identify anthropometric parameters that influence BAT mass and activity and thus the potential efficacy of envisioned drugs targeting this tissue to treat metabolic disease.
Methods: We analyzed 2,854 18F-FDG PET/CT scans from 1,644 patients and identified 98 scans from 81 patients with active BAT. We quantified the volume of active BAT depots (mean values in mL ± SD: total BAT, 162 ± 183 [n = 98]; cervical, 40 ± 37 [n = 53]; supraclavicular, 66 ± 68 [n = 71]; paravertebral, 51 ± 53 [n = 69]; mediastinal, 43 ± 40 [n = 51]; subphrenic, 21 ± 21 [n = 29]). Because only active BAT is detectable by 18F-FDG uptake, these numbers underestimate the total amount of BAT. Considering only 32 scans of the highest activity as categorized by a visual scoring strategy, we determined a mean total BAT volume of 308 ± 208 mL. In 30 BAT-positive patients with 3 or more repeated scans, we calculated a much higher mean probability to redetect active BAT (52% ± 25%) as compared with the overall prevalence of 4.9%. We calculated a BAT activity index (BFI) based on volume and intensity of individual BAT depots.
Results: We detected higher total BFI in younger patients (P = 0.009), whereas sex, body mass index, height, mass, outdoor temperature, and blood parameters did not affect total or depot-specific BAT activity. Surprisingly, renal creatinine clearance as estimated from mass, age, and plasma creatinine was a significant predictor of BFI on the total (P = 0.005) as well as on the level of several individual depots. In summary, we detected a high amount of more than 300 mL of BAT tissue.
Conclusion: BAT-positive patients represent a group with a higher than usual probability to activate BAT during a scan. Estimated renal creatinine clearance correlated with the extent of activated BAT in a given scan. These data imply an efficacy of drugs targeting BAT to treat metabolic disease that is at the same time higher and subject to a larger individual variation than previously assumed.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  FDG; brown adipose tissue; positron emission tomography

Mesh:

Substances:

Year:  2017        PMID: 28104743     DOI: 10.2967/jnumed.116.183988

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Mapping of human brown adipose tissue in lean and obese young men.

Authors:  Brooks P Leitner; Shan Huang; Robert J Brychta; Courtney J Duckworth; Alison S Baskin; Suzanne McGehee; Ilan Tal; William Dieckmann; Garima Gupta; Gerald M Kolodny; Karel Pacak; Peter Herscovitch; Aaron M Cypess; Kong Y Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 2.  Contribution of brown adipose tissue to human energy metabolism.

Authors:  Rodrigo Fernández-Verdejo; Kara L Marlatt; Eric Ravussin; Jose E Galgani
Journal:  Mol Aspects Med       Date:  2019-07-16

3.  No evidence for brown adipose tissue activation after creatine supplementation in adult vegetarians.

Authors:  Niels J Connell; Daniel Doligkeit; Charlotte Andriessen; Esther Kornips-Moonen; Yvonne M H Bruls; Vera B Schrauwen-Hinderling; Tineke van de Weijer; Wouter D van Marken-Lichtenbelt; Bas Havekes; Lawrence Kazak; Bruce M Spiegelman; Joris Hoeks; Patrick Schrauwen
Journal:  Nat Metab       Date:  2021-01-18

4.  Heterogeneity in the perirenal region of humans suggests presence of dormant brown adipose tissue that contains brown fat precursor cells.

Authors:  Naja Z Jespersen; Amir Feizi; Eline S Andersen; Sarah Heywood; Helle B Hattel; Søren Daugaard; Lone Peijs; Per Bagi; Bo Feldt-Rasmussen; Heidi S Schultz; Ninna S Hansen; Rikke Krogh-Madsen; Bente K Pedersen; Natasa Petrovic; Søren Nielsen; Camilla Scheele
Journal:  Mol Metab       Date:  2019-03-15       Impact factor: 7.422

Review 5.  Brown adipose tissue and glucose homeostasis - the link between climate change and the global rise in obesity and diabetes.

Authors:  Michael E Symonds; Grace Farhat; Peter Aldiss; Mark Pope; Helen Budge
Journal:  Adipocyte       Date:  2018-12-03       Impact factor: 4.534

Review 6.  Metabolic adaptation and maladaptation in adipose tissue.

Authors:  Edward T Chouchani; Shingo Kajimura
Journal:  Nat Metab       Date:  2019-01-21

7.  Reduced brown adipose tissue activity during cold exposure is a metabolic feature of the human thrifty phenotype.

Authors:  Tim Hollstein; Karyne Vinales; Kong Y Chen; Aaron M Cypess; Alessio Basolo; Mathias Schlögl; Jonathan Krakoff; Paolo Piaggi
Journal:  Metabolism       Date:  2021-01-18       Impact factor: 8.694

8.  The impact of using BARCIST 1.0 criteria on quantification of BAT volume and activity in three independent cohorts of adults.

Authors:  Borja Martinez-Tellez; Kimberly J Nahon; Guillermo Sanchez-Delgado; Gustavo Abreu-Vieira; Jose M Llamas-Elvira; Floris H P van Velden; Lenka M Pereira Arias-Bouda; Patrick C N Rensen; Mariëtte R Boon; Jonatan R Ruiz
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

9.  Electron Density of Adipose Tissues Determined by Phase-Contrast Computed Tomography Provides a Measure for Mitochondrial Density and Fat Content.

Authors:  Lorenz Birnbacher; Stefanie Maurer; Katharina Scheidt; Julia Herzen; Franz Pfeiffer; Tobias Fromme
Journal:  Front Physiol       Date:  2018-06-15       Impact factor: 4.566

Review 10.  Recent advances in our understanding of brown and beige adipose tissue: the good fat that keeps you healthy.

Authors:  Michael E Symonds; Peter Aldiss; Mark Pope; Helen Budge
Journal:  F1000Res       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.